Chanel’s Sales Jump 16% as Capri Holdings’ Revenue Falls 3.5%; P&G Targets Wellness with Thorne Deal
Lifestyle

Chanel’s Sales Jump 16% as Capri Holdings’ Revenue Falls 3.5%; P&G Targets Wellness with Thorne Deal

By Sophie Laurent 3 min read

Luxury Brands Feel Divergent Pressures

In the first half of 2024, Chanel reported a 16 percent increase in sales, while Capri Holdings disclosed a 3.5 percent decline in revenue. Meanwhile, Procter & Gamble announced plans to buy wellness brand Thorne. The figures were released this week, highlighting contrasting fortunes among luxury and consumer‑goods giants.

Analysts attribute Chanel’s surge to strong demand for designer Matthieu Blazy’s spring‑summer collections, which launched in March and attracted affluent shoppers. The French house also benefited from higher average transaction values and robust online performance. By contrast, Capri’s dip reflects slower growth in its Michael Kors and Versace lines, as consumers curb discretionary spending amid lingering economic uncertainty. P&G’s acquisition of Thorne signals a strategic push into the health‑and‑wellness segment, aiming to diversify its product portfolio beyond traditional household goods.

Chanel’s 16 percent rise translates to roughly €10 billion in additional revenue, according to Bloomberg. The brand’s focus on limited‑edition pieces and personalized service has resonated with high‑net‑worth clients seeking exclusivity. „Our customers are looking for timeless pieces that also feel fresh,” a Chanel spokesperson said, emphasizing the appeal of Blazy’s modern aesthetic.

Will P&G’s Wellness Push Reshape Consumer Health?

Capri Holdings, which owns Michael Kors, Versace and Jimmy Choo, reported a 3.5 percent revenue contraction, equating to a loss of about $200 million. The company cited weaker demand in North America and Europe, where price‑sensitive shoppers have delayed purchases. Executives are re‑evaluating inventory levels and accelerating digital initiatives to offset the slowdown.

P&G’s move to acquire Thorne, a firm known for premium supplements and diagnostic testing, marks its first major entry into the wellness space. The deal, valued at roughly $1.3 billion, aims to leverage Thorne’s scientific expertise and loyal customer base. „Integrating Thorne’s capabilities aligns with our long‑term vision of holistic health solutions,” a P&G executive explained.

Industry observers suggest the acquisition could accelerate P&G’s diversification, reducing reliance on traditional categories like personal care and cleaning products. If successful, the merger may prompt other consumer‑goods conglomerates to explore similar health‑focused acquisitions, reshaping market dynamics.

The contrasting results underscore a shifting luxury landscape and a broader consumer‑goods sector in transition. Chanel’s growth hints at resilient demand for high‑end fashion, while Capri’s decline signals caution among shoppers. P&G’s wellness foray may set a precedent for future strategic moves, potentially redefining how large manufacturers address health‑conscious consumers.

Frequently Asked Questions

What drove Chanel’s sales surge in the first half of 2024? The rise stemmed from strong consumer interest in Matthieu Blazy’s new collections, higher average spend per customer, and effective online sales channels.

Why did Capri Holdings experience a revenue drop? Capri’s decline resulted from weaker demand for its core brands, especially in North America and Europe, where shoppers have become more price‑sensitive.

How might P&G’s acquisition of Thorne affect its business strategy? The purchase expands P&G’s portfolio into the wellness market, allowing it to offer supplements and health diagnostics, which could diversify revenue and attract health‑focused consumers.

Content written by Sophie Laurent for perfect-routine.com editorial team, AI-assisted.

Leave a comment